@article{CDT27009,
author = {Emanuel Kaltenecker and Julia Schleihauf and Christian Meierhofer and Nerejda Shehu and Naira Mkrtchyan and Alfred Hager and Andreas Kühn and Julie Cleuziou and Karin Klingel and Heide Seidel and Martin Zenker and Peter Ewert and Gabriele Hessling and Cordula M. Wolf},
title = {Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy},
journal = {Cardiovascular Diagnosis and Therapy},
volume = {9},
number = {Suppl 2},
year = {2019},
keywords = {},
abstract = {Background: To compare outcome and cardiac pathology between patients with Noonan syndrome (N-HCM) and sarcomere protein-associated (S-HCM) childhood onset hypertrophic cardiomyopathy (HCM).
Methods: Clinical data were recorded from medical charts. Primary endpoint was survival. Secondary endpoints were survival without hospitalization, without intervention or without arrhythmic events. Functional clinical status and results from genetic testing, imaging, electrocardiographic (ECG) studies, cardiopulmonary exercise testing (CPET) and histopathology were compared between groups.
Results: Childhood HCM was diagnosed in 29 N-HCM and 34 S-HCM patients. Follow-up time was greater than 10 years in more than half of all patients. Mortality was below 7% and not different between groups. Children with N-HCM presented at a younger age and there was less time of survival without hospitalization for heart failure or intervention in N-HCM compared to S-HCM patients. Clinical functional status improved over time in N-HCM patients. On long-term follow-up, left ventricular posterior wall thickness indexed to body surface area decreased in N-HCM and increased in S-HCM patients. There was a trend to lower risk for severe arrhythmic events in N-HCM patients and only S-HCM individuals received an implantable cardioverter-defibrillator. There were no differences between groups in ventricular function, ECG and CPET parameters. Myocardial fibrosis as assessed by histopathology of myocardial specimens and cardiovascular magnetic resonance with late gadolinium enhancement or T1 mapping was present in both groups.
Conclusions: When compared to S-HCM patients, children with N-HCM have increased morbidity during early disease course, but favorable long-term outcome with low mortality, stagnation of myocardial hypertrophy, and low risk for malignant arrhythmias.},
issn = {2223-3660}, url = {https://cdt.amegroups.org/article/view/27009}
}